REGEN BIOPHARMA, INC. (RGBP)

0.00 +0.00% (+0.00)

Over 1M: +0.0%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

0 0 0
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q4 '23 — Revenue: 141.6K Q4 '23 — Operating Cash Flow: -23.4K Q1 '24 — Revenue: 59.1K Q1 '24 — Operating Cash Flow: -162.3K Q2 '24 — Revenue: 59.1K Q2 '24 — Operating Cash Flow: -209.3K Q3 '24 — Revenue: 59.1K Q3 '24 — Operating Cash Flow: -172.6K Q4 '24 — Revenue: 59.4K Q4 '24 — Operating Cash Flow: -207.3K Q1 '25 — Revenue: 59.1K Q1 '25 — Operating Cash Flow: -66.4K Q2 '25 — Revenue: 59.1K Q2 '25 — Operating Cash Flow: -101.2K Q3 '25 — Revenue: 59.1K Q3 '25 — Operating Cash Flow: -56K Q4 '25 — Revenue: 59.4K Q4 '25 — Operating Cash Flow: -160K Q1 '26 — Revenue: 59.1K Q1 '26 — Operating Cash Flow: -197.9K Q2 '26 — Revenue: 59.1K Q2 '26 — Operating Cash Flow: -63.2K Q3 '26 — Revenue: 59.1K Q3 '26 — Operating Cash Flow: -24.1K -160K -80K 0 80K 160K
Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26 Q3 '26
Revenue Operating Cash Flow Free Cash Flow

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

3.0
OE margin -188.2%
Oper. margin -339.8%
Accruals -257.6%
FCF margin -188.2%
OCF margin -188.2%
Profit margin -501.4%
ROA -412.5%
Capex / sales —
EBITDA margin —
Gross margin —
OCF / EBIT —
ROCE —
ROE —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.5
RPO / sales 5.3×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

1.2
ND/EBITDA —
Current ratio 0.058×
Cash / Debt 0.00033×
F-score 2.6 pts
Quick ratio 0.047×
Cash runway —
Debt / Eq —
Debt payback —
Equity / Assets —
Net debt / Eq —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

2.5
Sales CAGR 4Y +40.2%
Sales/sh Y/Y -82.5%
Sales Q/Q +0.0%
Shares change +473.0%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.